
Technology
Viewpoints
Filter by:
Federal Trade Commission Supercharges AI Regulatory Powers — AI: The Washington Report
November 30, 2023 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
Read about the FTC’s preauthorization of a compulsory process in investigations relating to AI and a new AI bill supported by a bipartisan group of Commerce Committee senators in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.
Biden Executive Order Calls for HHS to Establish Health Care-Specific Artificial Intelligence Programs and Policies
November 2, 2023 | Blog | By Pat Ouellette, Lara Compton, Madison Castle
On October 30, 2023, the Biden Administration released and signed an Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence (Executive Order) that articulates White House priorities and policies related to the use and development of artificial intelligence (AI) across different sectors, including health care.
Mintz and Antler: A Game-Changing Partnership Boosting Legal Support for Startups Everywhere — Including Innovative Health Care Company “peri”
September 12, 2023 | Article | By Stephen Osborn
Read about how Mintz’s partnership with startup accelerator and venture capital firm Antler led to Mintz’s work for oral health innovator peri.
MintzTech Connect Industry News: Spotlight on mePrism
September 12, 2023 | Article | By Samuel Asher Effron
Read about mePrism, a technology company that helps customers remove their personal information from the internet.
MintzTech Connect: All Things Technology — September 2023
September 12, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers QSBS issues related to converting an LLC into a corporation, legal decisions regarding cryptocurrencies and whether they are subject to SEC regulation, how Mintz’s partnership with Antler led to our work for oral health innovator peri, and a spotlight on mePrism, a tech company that helps customers remove their personal information from the internet.
Mintz Venture Watch — Volume 5: A Report on Deal Trends from Q1 and Q2 2023
August 21, 2023 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
Despite choppy market conditions for private companies, the Mintz Venture Capital & Emerging Companies team remained busy advising emerging companies of all sizes and at all stages of growth across a wide range of industries. For the first half of 2023 we completed 72 transactions, with an aggregate deal value in excess of $1.6 billion. Below are a few highlighted transactions:
MintzTech Connect: All Things Technology — May 2023
May 24, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
Spring is in the air but it is a challenging time to understand which way the wind is blowing on the emerging companies space. On the one hand, we saw a pause in investment activity at the end of 2022 and the first few months in 2023. On the other hand, we have seen a noticeable uptick of investment activity in the last six weeks. Again, on the one hand (a different set of hands) we recently saw a significant market correction in terms of valuations. But on the other hand, we have not seen a lot of the more punitive investment terms such as multiple participating preferences or pay to play provisions that we witnessed in the great recession in 2009 and the post bubble period in 2001.
MintzTech Connect Industry News: Spotlight on Coefficient
May 24, 2023 | Article | By Daniel DeWolf
Coefficient is a B2B SaaS platform that enables users to improve business insights and increase productivity for operations, analyst and finance professionals at enterprises of all sizes. Founded in 2019 and based in San Francisco, Coefficient recently raised $18 million in a Series A financing round from Battery Ventures, S28 Capital and Foundation Capital to grow its platform.
MintzTech Connect: All Things Technology — February 2023
February 21, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers the nuanced venture capital marketplace, the rising trend of extension rounds for emerging companies, matching investment funds available for New York early stage start-ups, and a spotlight on Moolah Kicks, the first and only sneaker made to biomechanically fit female athletes.
MintzTech Connect Industry News: Spotlight on Moolah Kicks
February 15, 2023 | Article | By Daniel DeWolf
Read about Moolah Kicks, the first and only women’s basketball brand with sneakers made to biomechanically fit female athletes.
Mintz Venture Watch — Volume 4: A Report on Deal Trends from 2022
February 9, 2023 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
This edition of Mintz Venture Watch reports on the firm’s VC transaction activity in 2022, including data for Q3 and Q4. Mintz represented issuers and investors in the life sciences, cybersecurity, energy, and other sectors in more than 128 transactions valued at more than $3 billion in 2022.
MintzTech Connect: All Things Technology — December 2022
December 7, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers top ways to accelerate the growth of emerging companies, our From the Edge podcast on how to run an effective board meeting, and a spotlight on SuperAngel.Fund and its founder Ben Zises.
MintzTech Connect Industry News: Spotlight on Ben Zises and SuperAngel.Fund
December 7, 2022 | Article | By Daniel DeWolf
Read about Ben Zises, angel investor, fund manager, and founder of SuperAngel.Fund, the fund’s investments in quip and other consumer product companies, and the evolution of the fund.
MintzTech Connect: All Things Technology — September 2022
September 19, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
MintzTech Connect Industry News: Spotlight on Adgile Media Group
September 19, 2022 | Article | By Daniel DeWolf
Read about Adgile Media Group, a national out-of-home (OOH) advertising company that provides delivery vehicle wraps and uses a data platform to track exposure to the ads.
MintzTech Connect Industry News: Spotlight on Radicle Science
September 19, 2022 | Article | By Jeremy Glaser
Read about Radicle Science, a San Diego AI–driven health tech start-up with a virtual, direct-to-consumer (D2C) clinical trial model designed to validate and predict the effects of health and wellness products.
Mintz Venture Watch — Volume 3: A Report on Deal Trends from Q1 and Q2 2022
August 17, 2022 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
NFTs: A Flash in the Crypto Pan or Virtual Gold? (Part 1)
August 2, 2022 | Blog | By Edmund P. Daley, Cory S. Flashner, Frank Gerratana
Non-fungible tokens (“NFTs”) grabbed mainstream attention in 2021 with news of digital art and collectibles selling for millions. But headlines reporting NFTs selling for millions were short-lived. “Crypto winter” cast a chill across the crypto world – prices and interest in the digital art and images that became synonymous with NFTs plummeted.
Benefits of Using Copyrights to Protect Artificial Intelligence and Machine Learning Inventions
July 11, 2022 | Blog | By Monique Winters Macek, Meena Seralathan
We previously discussed which portions of an artificial intelligence/machine-learning (“AI/ML”) platform could be patented or protected under trade secret, such as related to biotech and synthetic biology. Equally important to the discussion of how to protect components of an AI/ML platform, however, is the extent to which copyright protection may be useful or beneficial to the developer of the platform. In this post, we explain what can be protected by copyright in an AI/ML platform. We also explore when it is appropriate to protect portions of AI/ML platforms using a copyright, how to properly enforce copyrights, as well as when to consider using copyright protection over patent or trade secret protection.
Five Tips For Every In-House Counsel Launching an Open Source Software Program
July 5, 2022 | Blog | By Marguerite McConihe, Greg Penoyer
Used properly, Open Source Software (OSS) is an excellent tool. It saves your business time and money, enables interoperability of product platforms, and developers love it. But used improperly, it can be financially and operationally devastating. For example, the statutory damages for failure to properly adhere to the OSS copyright notice can be up to $150,000 per act of infringement. Those damages can quickly add up to serious consequences, whether preventing a sale or merger of your company or the destruction of the value of the affected products. Another serious risk is that once OSS is used in your code base and deployed in distributed products, if your tech teams are not monitoring and applying bug fixes, known vulnerabilities become Trojan horses of opportunity for bad actors. The good news is that protecting your company from these types of risks is rather simple. We have outlined below key steps and processes in-house counsel should take to work with your business stakeholders to mitigate these risks.
Explore Other Viewpoints:
- Data Centers & Digital Infrastructure
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- DEI Legal Developments
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- EnforceMintz
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Sustainable Energy & Infrastructure
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Unified Patent Court (UPC)
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology